Smad2/3 proteins are required for immobilization-induced skeletal muscle atrophy

Toshimi Tando, Akiyoshi Hirayama, Mitsuru Furukawa, Yuiko Sato, Tami Kobayashi, Atsushi Funayama, Arihiko Kanaji, Wu Hao, Ryuichi Watanabe, Mayu Morita, Takatsugu Oike, Kana Miyamoto, Tomoyoshi Soga, Masatoshi Nomura, Akihiko Yoshimura, Masaru Tomita, Morio Matsumoto, Masaya Nakamura, Yoshiaki Toyama, Takeshi Miyamoto

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Skeletal muscle atrophy promotes muscle weakness, limiting activities of daily living. However, mechanisms underlying atrophy remain unclear. Here, we show that skeletal muscle immobilization elevates Smad2/3 protein but not mRNA levels in muscle, promoting atrophy. Furthermore, we demonstrate that myostatin, which negatively regulates muscle hypertrophy, is dispensable for denervation-induced muscle atrophy and Smad2/3 protein accumulation. Moreover, muscle-specific Smad2/3-deficient mice exhibited significant resistance to denervation-induced muscle atrophy. In addition, expression of the atrogenes Atrogin-1 and MuRF1, which underlie muscle atrophy, did not increase in muscles of Smad2/3-deficient mice following denervation. We also demonstrate that serum starvation promotes Smad2/3 protein accumulation in C2C12 myogenic cells, an in vitro muscle atrophy model, an effect inhibited by IGF1 treatment. In vivo, we observed IGF1 receptor deactivation in immobilized muscle, even in the presence of normal levels of circulating IGF1. Denervation-induced muscle atrophy was accompanied by reduced glucose intake and elevated levels of branched-chain amino acids, effects that were Smad2/3-dependent. Thus, muscle immobilization attenuates IGF1 signals at the receptor rather than the ligand level, leading to Smad2/3 protein accumulation, muscle atrophy, and accompanying metabolic changes.

Original languageEnglish
Pages (from-to)12184-12194
Number of pages11
JournalJournal of Biological Chemistry
Volume291
Issue number23
DOIs
Publication statusPublished - 2016 Jun 3

Fingerprint

Smad2 Protein
Muscular Atrophy
Immobilization
Muscle
Skeletal Muscle
Denervation
Proteins
Muscles
Myostatin
Branched Chain Amino Acids
Muscle Weakness
Activities of Daily Living
Starvation
Hypertrophy
Atrophy

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Tando, T., Hirayama, A., Furukawa, M., Sato, Y., Kobayashi, T., Funayama, A., ... Miyamoto, T. (2016). Smad2/3 proteins are required for immobilization-induced skeletal muscle atrophy. Journal of Biological Chemistry, 291(23), 12184-12194. https://doi.org/10.1074/jbc.M115.680579

Smad2/3 proteins are required for immobilization-induced skeletal muscle atrophy. / Tando, Toshimi; Hirayama, Akiyoshi; Furukawa, Mitsuru; Sato, Yuiko; Kobayashi, Tami; Funayama, Atsushi; Kanaji, Arihiko; Hao, Wu; Watanabe, Ryuichi; Morita, Mayu; Oike, Takatsugu; Miyamoto, Kana; Soga, Tomoyoshi; Nomura, Masatoshi; Yoshimura, Akihiko; Tomita, Masaru; Matsumoto, Morio; Nakamura, Masaya; Toyama, Yoshiaki; Miyamoto, Takeshi.

In: Journal of Biological Chemistry, Vol. 291, No. 23, 03.06.2016, p. 12184-12194.

Research output: Contribution to journalArticle

Tando, T, Hirayama, A, Furukawa, M, Sato, Y, Kobayashi, T, Funayama, A, Kanaji, A, Hao, W, Watanabe, R, Morita, M, Oike, T, Miyamoto, K, Soga, T, Nomura, M, Yoshimura, A, Tomita, M, Matsumoto, M, Nakamura, M, Toyama, Y & Miyamoto, T 2016, 'Smad2/3 proteins are required for immobilization-induced skeletal muscle atrophy', Journal of Biological Chemistry, vol. 291, no. 23, pp. 12184-12194. https://doi.org/10.1074/jbc.M115.680579
Tando T, Hirayama A, Furukawa M, Sato Y, Kobayashi T, Funayama A et al. Smad2/3 proteins are required for immobilization-induced skeletal muscle atrophy. Journal of Biological Chemistry. 2016 Jun 3;291(23):12184-12194. https://doi.org/10.1074/jbc.M115.680579
Tando, Toshimi ; Hirayama, Akiyoshi ; Furukawa, Mitsuru ; Sato, Yuiko ; Kobayashi, Tami ; Funayama, Atsushi ; Kanaji, Arihiko ; Hao, Wu ; Watanabe, Ryuichi ; Morita, Mayu ; Oike, Takatsugu ; Miyamoto, Kana ; Soga, Tomoyoshi ; Nomura, Masatoshi ; Yoshimura, Akihiko ; Tomita, Masaru ; Matsumoto, Morio ; Nakamura, Masaya ; Toyama, Yoshiaki ; Miyamoto, Takeshi. / Smad2/3 proteins are required for immobilization-induced skeletal muscle atrophy. In: Journal of Biological Chemistry. 2016 ; Vol. 291, No. 23. pp. 12184-12194.
@article{b03c81d52b4e48429de2b5dffe4145c7,
title = "Smad2/3 proteins are required for immobilization-induced skeletal muscle atrophy",
abstract = "Skeletal muscle atrophy promotes muscle weakness, limiting activities of daily living. However, mechanisms underlying atrophy remain unclear. Here, we show that skeletal muscle immobilization elevates Smad2/3 protein but not mRNA levels in muscle, promoting atrophy. Furthermore, we demonstrate that myostatin, which negatively regulates muscle hypertrophy, is dispensable for denervation-induced muscle atrophy and Smad2/3 protein accumulation. Moreover, muscle-specific Smad2/3-deficient mice exhibited significant resistance to denervation-induced muscle atrophy. In addition, expression of the atrogenes Atrogin-1 and MuRF1, which underlie muscle atrophy, did not increase in muscles of Smad2/3-deficient mice following denervation. We also demonstrate that serum starvation promotes Smad2/3 protein accumulation in C2C12 myogenic cells, an in vitro muscle atrophy model, an effect inhibited by IGF1 treatment. In vivo, we observed IGF1 receptor deactivation in immobilized muscle, even in the presence of normal levels of circulating IGF1. Denervation-induced muscle atrophy was accompanied by reduced glucose intake and elevated levels of branched-chain amino acids, effects that were Smad2/3-dependent. Thus, muscle immobilization attenuates IGF1 signals at the receptor rather than the ligand level, leading to Smad2/3 protein accumulation, muscle atrophy, and accompanying metabolic changes.",
author = "Toshimi Tando and Akiyoshi Hirayama and Mitsuru Furukawa and Yuiko Sato and Tami Kobayashi and Atsushi Funayama and Arihiko Kanaji and Wu Hao and Ryuichi Watanabe and Mayu Morita and Takatsugu Oike and Kana Miyamoto and Tomoyoshi Soga and Masatoshi Nomura and Akihiko Yoshimura and Masaru Tomita and Morio Matsumoto and Masaya Nakamura and Yoshiaki Toyama and Takeshi Miyamoto",
year = "2016",
month = "6",
day = "3",
doi = "10.1074/jbc.M115.680579",
language = "English",
volume = "291",
pages = "12184--12194",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "23",

}

TY - JOUR

T1 - Smad2/3 proteins are required for immobilization-induced skeletal muscle atrophy

AU - Tando, Toshimi

AU - Hirayama, Akiyoshi

AU - Furukawa, Mitsuru

AU - Sato, Yuiko

AU - Kobayashi, Tami

AU - Funayama, Atsushi

AU - Kanaji, Arihiko

AU - Hao, Wu

AU - Watanabe, Ryuichi

AU - Morita, Mayu

AU - Oike, Takatsugu

AU - Miyamoto, Kana

AU - Soga, Tomoyoshi

AU - Nomura, Masatoshi

AU - Yoshimura, Akihiko

AU - Tomita, Masaru

AU - Matsumoto, Morio

AU - Nakamura, Masaya

AU - Toyama, Yoshiaki

AU - Miyamoto, Takeshi

PY - 2016/6/3

Y1 - 2016/6/3

N2 - Skeletal muscle atrophy promotes muscle weakness, limiting activities of daily living. However, mechanisms underlying atrophy remain unclear. Here, we show that skeletal muscle immobilization elevates Smad2/3 protein but not mRNA levels in muscle, promoting atrophy. Furthermore, we demonstrate that myostatin, which negatively regulates muscle hypertrophy, is dispensable for denervation-induced muscle atrophy and Smad2/3 protein accumulation. Moreover, muscle-specific Smad2/3-deficient mice exhibited significant resistance to denervation-induced muscle atrophy. In addition, expression of the atrogenes Atrogin-1 and MuRF1, which underlie muscle atrophy, did not increase in muscles of Smad2/3-deficient mice following denervation. We also demonstrate that serum starvation promotes Smad2/3 protein accumulation in C2C12 myogenic cells, an in vitro muscle atrophy model, an effect inhibited by IGF1 treatment. In vivo, we observed IGF1 receptor deactivation in immobilized muscle, even in the presence of normal levels of circulating IGF1. Denervation-induced muscle atrophy was accompanied by reduced glucose intake and elevated levels of branched-chain amino acids, effects that were Smad2/3-dependent. Thus, muscle immobilization attenuates IGF1 signals at the receptor rather than the ligand level, leading to Smad2/3 protein accumulation, muscle atrophy, and accompanying metabolic changes.

AB - Skeletal muscle atrophy promotes muscle weakness, limiting activities of daily living. However, mechanisms underlying atrophy remain unclear. Here, we show that skeletal muscle immobilization elevates Smad2/3 protein but not mRNA levels in muscle, promoting atrophy. Furthermore, we demonstrate that myostatin, which negatively regulates muscle hypertrophy, is dispensable for denervation-induced muscle atrophy and Smad2/3 protein accumulation. Moreover, muscle-specific Smad2/3-deficient mice exhibited significant resistance to denervation-induced muscle atrophy. In addition, expression of the atrogenes Atrogin-1 and MuRF1, which underlie muscle atrophy, did not increase in muscles of Smad2/3-deficient mice following denervation. We also demonstrate that serum starvation promotes Smad2/3 protein accumulation in C2C12 myogenic cells, an in vitro muscle atrophy model, an effect inhibited by IGF1 treatment. In vivo, we observed IGF1 receptor deactivation in immobilized muscle, even in the presence of normal levels of circulating IGF1. Denervation-induced muscle atrophy was accompanied by reduced glucose intake and elevated levels of branched-chain amino acids, effects that were Smad2/3-dependent. Thus, muscle immobilization attenuates IGF1 signals at the receptor rather than the ligand level, leading to Smad2/3 protein accumulation, muscle atrophy, and accompanying metabolic changes.

UR - http://www.scopus.com/inward/record.url?scp=84974685720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84974685720&partnerID=8YFLogxK

U2 - 10.1074/jbc.M115.680579

DO - 10.1074/jbc.M115.680579

M3 - Article

C2 - 27129272

AN - SCOPUS:84974685720

VL - 291

SP - 12184

EP - 12194

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 23

ER -